Autologous Micrografting vs. Other Treatments
See how AMT® Micrografting compares to common alternatives in safety, potency, and convenience. Discover why autologous micrografting represents the gold standard in hair restoration technology.
90%+
Cell Viability
0%
Rejection Risk
1
Session
Why Choose Autologous Micrografting?
Comprehensive comparison of AMT® vs traditional treatments
Regenera Activa (AMT®)
SUPERIORUses patient's own tissue
Avoiding rejection risk completely
+90% cell viability
Extracted and applied in one session
Human, tissue-specific exosomes
Only treatment with this advantage
Minimally invasive
No surgery, no downtime
95%
Success Rate
0%
Rejection Risk
24
Months Results
Other Treatments
LIMITEDForeign substances
May introduce rejection risk
Lower cell viability
Lower concentration or no live cells
Non-human exosomes
Lacking tissue specificity
Invasive procedures
Some require incisions or multiple sessions
75%
Success Rate
5-15%
Rejection Risk
6-12
Months Results
Clinical Comparison Table
Detailed analysis of treatment parameters and outcomes
Parameter | AMT® Micrografting | Other Treatments |
---|---|---|
Tissue Source | Patient's Own | External/Donor |
Cell Viability | 90%+ | 30-60% |
Rejection Risk | 0% | 5-15% |
Exosome Source | Human Tissue-Specific | Non-Human/Generic |
Invasiveness | Minimal | Moderate-High |
Sessions Required | 1 | Multiple |
Results Duration | 12-24 months | 6-12 months |
Key Advantages of AMT®
Why autologous micrografting is the superior choice
Zero Rejection Risk
Uses your own tissue, eliminating any risk of rejection or allergic reactions
Tissue-Specific Exosomes
Human exosomes that are specifically designed for hair follicle regeneration
Long-Lasting Results
Results that last 12-24 months with just one treatment session
Natural & Safe
Completely natural process using your body's own regenerative capabilities
Experience the Gold Standard in Hair Restoration
Choose AMT® Micrografting for the most advanced, safe, and effective hair restoration treatment. Join thousands of patients who have experienced the difference with autologous micrografting.